Option chain shows key data for Pharming's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Pharming.

Pharming (NASDAQ:PHAR) Stock, Option Chain

Pharming

Pharming Group is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. It is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines to serve the unserved rare disease patients. Its product includes Ruconest. The revenue is generated from the United States.

movers image

News

Intraday Update

Markets

Movers

Trading Ideas

ACDC

ARRY

CMPS

CRMD

ENPH

GLPG

GTLS

GYRE

LUNR

PHAR

PRTC

RCKT

XPEV

Galapagos, XPeng, CorMedix And Other Big Stocks Moving Higher On Monday

Headquarters_Rahway-Site-Entrance_HI

AMKR

ATPC

BIMI

BLMZ

CALC

CLDX

CNSP

CRWD

CVLT

EKSO

ENVB

FFIV

HAYW

HLIT

IMNN

INVO

ISPO

JBLU

JTAI

LSCC

LUMN

MBIN

NIPG

NVAX

ONEW

PCSA

PYPL

RGEN

RMBS

SMRT

TLRY

TRNS

TWOU

VBIV

VRNS

VSEE

Why Merck Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Tuesday&#39;s Mid-Day Session

PayPal Operations Center in Dublin, Ireland

HSII

NVCR

PEGA

SAVE

SWIM

ZBRA

PayPal Posts Upbeat Earnings, Joins Sprouts Farmers Market, Stanley Black &amp; Decker, Phillips 66 And Other Big Stocks Moving Higher On Tuesday

Pharming Group N.V. - ADS, each representing 10 ordinary shares

Pharming Group

PHARMARON BEIJING U/ADR by PHARMARON BEIJING CO LTD.

PHarol SGPS SA

PharmChem Inc

PHARMA FOODS INTL CO by Pharma Foods International Co., Ltd.

Pharma Foods International Co Ltd

Pharma Mar SA

PHARM-BIO SERV INC by Pharma-Bio Serv, Inc.

Pharma-Bio Serv Inc

PharmaCielo Ltd

PHARMACOM BIOVET INC by PharmaCom BioVet, Inc.

PharmaCom BioVet Inc

PharmaCyte Biotech Inc

PHARMAROTH LABS INC by PharmaRoth Labs, Inc.

PharmaRoth Labs Inc

PHARMATHER HLDGS LTD by PharmaTher Holdings Ltd.

PharmaTher Holdings Ltd

Pharmadrug Inc

Pharmagen Inc

PHARMAGREEN BIOTECH INC by Pharmagreen Biotech Inc.

Pharmagreen Biotech Inc

Pharmala Biotech Holdings Inc

PHARMALA BIOTECH HLDG INC by PharmAla Biotech Holdings Inc.

PHARMARON BEIJING CO LTD by PHARMARON BEIJING CO LTD.

Pharmaron Beijing Co Ltd

PHARMING GROUP NV ORD by Pharming Group NV

Pharnext SA

Pharos Energy PLC

Pharvaris NV

Pharming Group N.V. 2024 Q2 - Results - Earnings Call Presentation

Joseph Pantginis, an analyst from H.C. Wainwright, reiterated the Buy rating on Pharming Group (PHAR – Research Report). The associated price targe...

Pharming Group's Joenja Garners Buy Rating Amid Regulatory Successes and Growth Potential

Oppenheimer analyst Jeff Jones maintained a Buy rating on Pharming Group (PHAR – Research Report) today and set a price target of $31.00. The compa...

Oppenheimer Sticks to Its Buy Rating for Pharming Group (PHAR)

H.C. Wainwright analyst Joseph Pantginis reiterated a Buy rating on Pharming Group (PHAR – Research Report) today and set a price target of $37.00....

Buy Rating Affirmed for Pharming Group on Leniolisib's Progress and Joenja's Market Expansion

There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Pharming Group (PHAR – Research Report) and MoonLake...

Analysts Offer Insights on Healthcare Companies: Pharming Group (PHAR) and MoonLake Immunotherapeutics (MLTX)

Pharming reports Q3 results

In a report released today, Joseph Pantginis from H.C. Wainwright reiterated a Buy rating on Pharming Group (PHAR – Research Report), with a price ...

Positive Outlook for Pharming Group Amidst Growth Opportunities and Leadership Transition

Pharming Group N.V. (PHAR) Q3 2024 Earnings Call Transcript

Oppenheimer analyst Jeff Jones lowered the firm's price target on Pharming (PHAR) to $30 from $31 and keeps an Outperform rating on the shares foll...

Pharming price target lowered to $30 from $31 at Oppenheimer

RBC Capital lowered the firm's price target on Pharming (PHAR) to EUR 1.60 from EUR 1.65 and keeps an Outperform rating on the shares. Published fi...

Pharming price target lowered to EUR 1.60 from EUR 1.65 at RBC Capital

MLTX

PHGUF

Press Releases

Pharming Group reports on results of the 2024 Annual General Meeting of Shareholders

Pharming Group to participate in June investor conferences

Pharming Group to report second quarter and first half 2024 financial results on August 1

Earnings

Pharming Group reports second quarter and first half 2024 financial results and provides business update

Pharming Group to participate in September investor conferences

General

Pharming announces marketing authorization in the U.K. for Joenja® (leniolisib)

Pharming Group announces start of Phase II clinical trial of leniolisib for primary immunodeficiencies (PIDs) with immune dysregulation

Pharming Group to report third quarter 2024 financial results on October 24

Pharming Group reports third quarter 2024 financial results and provides business update

Pharming Group to participate in November investor conference

Abivax

Altimmune

AnaptysBio

Astria Therapeutics

Anavex Life Sciences Corp. - Common Stock

Anavex Life Sciences

Perspective Therapeutics, Inc. Common Stock

Perspective Therapeutics

Corvus Pharmaceuticals, Inc. - Common Stock

Corvus Pharma

Exscientia Plc - American Depositary Shares

Exscientia

Humacyte

IGM Biosciences

Immunome

MeiraGTx Hldgs

Mineralys Therapeutics, Inc. - Common Stock

Mineralys Therapeutics

Mereo BioPharma Group plc - American Depositary Shares

Mereo BioPharma Group

Neurogene

Olema Pharmaceuticals, Inc. - Common Stock

Olema Pharmaceuticals

Organogenesis Hldgs

Oric Pharmaceuticals, Inc. - Common Stock

ORIC Pharmaceuticals

PureTech Health plc - American Depositary Shares

PureTech Health

Sana Biotechnology

Silence Therapeutics Plc - American Depository Share

Silence Therapeutics

Stoke Therapeutics

Savara

Tectonic Therapeutic, Inc. - Common Stock

Tectonic Therapeutic

Y-mAbs Therapeutics

Oppenheimer

HC Wainwright & Co.

Comments

Pharming

Pharming (PHAR) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga